然后在骨折端之间形成一个2厘米的间隙模拟粉碎性骨折，重复力学试验。
A 2-cm bone gap was then created at the fracture site to simulate comminution and the mechanical tests repeated.
结果：生物力学试验数据表明，接骨灵颗粒对兔桡骨骨折拉伸极限荷载、弯曲最大荷载、冲击值均显著高于对照组。
Result:the biomechanical test indicates that Jieguling granules' maximum loading of elongationmaximum loading of bend and data of impact supass control group.
目的对纳米锶磷灰石进行体外细胞毒性试验，评价其生物安全性，为将其应用于骨折临床修复奠定基础。
Objective Nano- fermorite was tested by in vitro cytotoxicity as first step for future use of this material as orthopedic implant.
类似的病人可以在试验和骨折诊所中查看到(表格1)。
Similar patients were seen in the trial and fracture clinic (Table 1).
以我们的经验，罗格列酮治疗骨折风险增加，与在其他试验如adopt中所观察到的相似。
In our experience, there is an increase in the hazard risk for fractures with rosiglitazone, similar to that seen in other trials such as ADOPT.
结论四肢爆炸伤在该试验中发生率高，局部组织毁损严重，骨折均为粉碎性骨折，且合并全身多处损伤。
Conclusion the incidence of limb injury hit by fragments is high, and the wounding is serious, fractures are all comminuted fracture and combined with multiple injuries is more.
大部分的肋骨骨折可经保守治疗治愈，近年经过临床试验表明选择性的肋骨内固定更有利于患者恢复。
Most of rib fractures can be cured conservatively, but it is better for patient's habilitation if they receive surgical stabilization selectively according to recent clinical trials.
结论现有的随机对照试验证据并不支持对颅底骨折患者预防性使用抗生素，无论其有无脑脊液漏的迹象。
Conclusions Currently available evidence from RCTs does not support prophylactic antibiotic use in patients with BSF, whether there is evidence of CSF leakage or not.
毒理试验和药效药理学试验显示：1、具有疏通骨折端或病灶局部的血液循环作用，促进毛细血管增生。
Toxicological testing and pharmacological testing reveal that: 1. This medicine can boost the blood circulation of fracture end or localized focus and promote the proliferation of blood capillary; 2.
方法随机选择住院骨折病人30例为试验组，30例为对照组。
Methods 60 in patients with fracture were divided randomly into experimental group and control group, 30 cases for each.
已经有很多临床试验研究了骨的抗再吸收治疗在预防骨密度丢失和骨折中的作用。
Numerous clinical trials have studied the role of bone antiresorptive therapy for prevention of bone density loss and fractures.
已经有很多临床试验研究了骨的抗再吸收治疗在预防骨密度丢失和骨折中的作用。
Numerous clinical trials have studied the role of bone antiresorptive therapy for prevention of bone density loss and fractures.
应用推荐